Difference between revisions of "CTSC:ARRA.AB.061610"

From NAMIC Wiki
Jump to: navigation, search
Line 6: Line 6:
 
# Progress to date  
 
# Progress to date  
 
# Review of image transfer policy in testing phase (unrelated to studies)  
 
# Review of image transfer policy in testing phase (unrelated to studies)  
# Establishment of task force to agree upon rules for frequency / timing of downloads for studies
+
# Establishment of task force to agree upon rules for frequency / timing of downloads for studies  
# Harvard Catalyst HIPAA officer
+
# Data terms of use 
# Future milestones
 
  
 
== Harvard Catalyst mi2b2 Advisory Board Meeting Minutes June 16, 2010 ==
 
== Harvard Catalyst mi2b2 Advisory Board Meeting Minutes June 16, 2010 ==
Line 22: Line 21:
 
* Sabune Winkler (Harvard Catalyst Regulatory Program)
 
* Sabune Winkler (Harvard Catalyst Regulatory Program)
 
* Min Kim (new HCat Regulatory Affairs Officer)
 
* Min Kim (new HCat Regulatory Affairs Officer)
 
+
* Ramin Khorasani (by phone)
* Steve Pieper
 
* Richard Robertson
 
* Dan Nigrin
 
* Ramin Khorasani
 
* Jesse Wei
 
* Bob Lenkinski
 
 
 
  
 
== Meeting Minutes ==
 
== Meeting Minutes ==
 
<br>
 
<br>
*'''Progress to date'''
+
'''Progress to date'''
 +
Shawn began by reviewing the project overview including the component software tools such as i2b2 and XNAT.  Bruce Rosen suggested thinking through what preliminary data we would need to succeed in garnering future grants to continue to advance the project when the ARRA funding ends.  Exploring sources for submitting grants (e.g. NCRR, NIBIB and broader NIH initiatives such as supplements to NA-MIC and/or i2b2).  Bruce suggests getting face time with NCRR program officers responsible for CTSCs and BIRN to build awareness of this project.
 +
<br>
 +
'''Review of image transfer policy in testing phase (unrelated to studies)'''
 +
The group approved of the decision to allow the transfer of test images from their PACS in the context of developing the software.
 +
<br>
 +
'''Data terms of use'''
 +
At the suggestion of Ramin, we will review with each individual site the current i2b2 IRB approval data sharing language for their site.  Since no cross site sharing is required for this project, that should be sufficient.  In future meetings we will re-visit this issue if any site has questions or suggestions for further consideration.

Revision as of 15:41, 16 June 2010

Home < CTSC:ARRA.AB.061610

Back to CTSC:ARRA supplement

Agenda:

  1. Progress to date
  2. Review of image transfer policy in testing phase (unrelated to studies)
  3. Establishment of task force to agree upon rules for frequency / timing of downloads for studies
  4. Data terms of use

Harvard Catalyst mi2b2 Advisory Board Meeting Minutes June 16, 2010

In attendance:

  • Bruce Rosen (by phone)
  • Valerie Humblet
  • Randy Gollub
  • Shawn Murphy
  • Chris Herrick
  • Diane Keogh
  • Sabune Winkler (Harvard Catalyst Regulatory Program)
  • Min Kim (new HCat Regulatory Affairs Officer)
  • Ramin Khorasani (by phone)

Meeting Minutes


Progress to date Shawn began by reviewing the project overview including the component software tools such as i2b2 and XNAT. Bruce Rosen suggested thinking through what preliminary data we would need to succeed in garnering future grants to continue to advance the project when the ARRA funding ends. Exploring sources for submitting grants (e.g. NCRR, NIBIB and broader NIH initiatives such as supplements to NA-MIC and/or i2b2). Bruce suggests getting face time with NCRR program officers responsible for CTSCs and BIRN to build awareness of this project.
Review of image transfer policy in testing phase (unrelated to studies) The group approved of the decision to allow the transfer of test images from their PACS in the context of developing the software.
Data terms of use At the suggestion of Ramin, we will review with each individual site the current i2b2 IRB approval data sharing language for their site. Since no cross site sharing is required for this project, that should be sufficient. In future meetings we will re-visit this issue if any site has questions or suggestions for further consideration.